Covered recipient · General Payments record
EUGIDE KASONGO OTHEPA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$253.24
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $253.24 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $102.18 | 1 |
| IBSA Pharma Inc. | $36.92 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.90 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.48 | 1 |
| UCB, Inc. | $19.15 | 1 |
| ITI, Inc. | $18.51 | 1 |
| Exact Sciences Corporation | $17.97 | 1 |
| ABBVIE INC. | $16.13 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $253.24 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.13 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105162411 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.48 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092482 | CMS |
| Exact Sciences Corporation | $17.97 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125821367 | CMS |
| IBSA Pharma Inc. | $14.64 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142987246 | CMS |
| IBSA Pharma Inc. | $22.28 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142987248 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.51 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143290893 | CMS |
| Lilly USA, LLC | $102.18 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970233 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.90 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153484040 | CMS |
| UCB, Inc. | $19.15 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143114961 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.